Drug-Facilitated Crimes & Sexual Assault

What is meant by a drug-facilitated crime?

The term describes a suspected crime involving the use of alcohol or other drugs to impair a person's awareness, memory, judgment, or ability to respond, or the exploitation of someone already impaired. Sexual assault is one example; similar toxicological questions may arise in other suspected crimes.

These matters can involve covert administration, forced consumption, or substances a person took voluntarily. Voluntary consumption of alcohol or a drug is not consent to sexual activity and does not make a person responsible for an assault.

The scientific review examines the available evidence without treating the allegation or a laboratory result as a predetermined conclusion.

Are these cases limited to GHB or so-called "date-rape drugs"?

No. Alcohol, prescription medicines, over-the-counter medicines, and illicit substances may be relevant. Restricting an investigation to a few widely publicized drugs can overlook other substances.

Alcohol and other drugs may also interact, affecting sedation, memory, coordination, or consciousness. The significance of a possible interaction depends on the substances, timing, individual circumstances, and available evidence; merely detecting more than one substance does not establish a particular effect.

Why is the timing of specimen collection important?

Drugs and their metabolites may be absorbed, distributed, broken down, and eliminated before specimens are collected. Some substances have short detection windows, and delayed collection can substantially reduce the likelihood of detection.

There is no single collection deadline or detection window that applies to every substance and specimen. Detectability depends on the drug, dose, specimen, elapsed time, analytical method, and other circumstances. A published collection recommendation is not a guarantee that a substance will remain detectable until that time.

Medical and forensic professionals should assess appropriate collection and testing promptly under applicable procedures and consent requirements. A delay does not make medical care, support, or a case review pointless.

Do blood and urine provide the same information?

No. Blood may provide information about substances circulating at collection, while urine may identify drugs or metabolites over a different and sometimes longer period. Neither specimen automatically establishes the person's condition at an earlier event.

A urine result generally cannot determine a person's degree of impairment at a particular time. A blood concentration also requires context, including collection timing, the substance, individual variation, and the rest of the evidence.

Specimen selection, collection, preservation, storage, and chain-of-custody documentation can affect the reliability and meaning of the findings.

Can a routine hospital drug screen rule out a drug-facilitated crime?

No. Clinical testing is directed toward patient care and may cover only selected substances or drug classes. A routine screen may not include the suspected drug, may use a reporting threshold unsuitable for a low-level exposure, or may not identify a specific substance.

Forensic testing may use different methods, reporting limits, and documentation. Whether additional or confirmatory testing would be useful depends on the question, the original methods, and the availability and condition of suitable specimens.

No single test detects every possible substance. A review should establish what was tested rather than assume that a report described as a "drug screen" was comprehensive.

Does a negative result mean the person was not drugged or assaulted?

No. A negative result means the reported substance was not detected under the conditions of that test. A substance may have been eliminated, may not have been included in the panel, or may have been present below the reporting limit.

A negative result does not prove that an assault did not occur or that a person's account is false. It also does not independently establish that drugging occurred. The conclusion must reflect the actual capabilities of the testing and the broader available evidence.

Does a positive result prove covert administration or incapacitation?

No. Detecting a substance or metabolite can support exposure, but usually does not establish who administered it, whether it was taken knowingly, the exact dose, or the person's capacity at the time of the event.

The review considers prescribed or other reported use, substances given during medical treatment, the timing of collection, the analytical findings, and other relevant records. Concentrations and known drug effects may help evaluate possible explanations, but a positive result alone does not prove intent, an assault, or legal incapacity.

Can memory gaps or unusual symptoms identify a particular drug?

Not reliably on their own. Memory gaps, drowsiness, confusion, and impaired coordination can have multiple explanations, including alcohol, different drugs, medical conditions, or the effects of trauma. Different substances can produce overlapping effects.

Reported symptoms and observations are relevant information, but they should not be treated as a laboratory identification of a particular substance. Conversely, incomplete recall is not, by itself, evidence that an account is untrue. The scientific assessment should state what can and cannot be inferred from the available information.

What records are useful for an independent review?

Relevant materials may include:

• A timeline of the suspected event, reported symptoms, medical care, and specimen collection, including uncertainties in the times.
• Available accounts and observations relevant to alertness, memory, coordination, and behavior.
• Relevant information about alcohol, prescription medicines, over-the-counter medicines, and other substances taken before or after the event.
• Medical and sexual assault forensic examination records, where appropriately authorized for review.
• Complete toxicology reports, the substances included in testing, methods, reporting limits, and available confirmation or quantitative results.
• Specimen identification, collection times, storage and preservation information, chain-of-custody records, and information about any remaining specimens.
• Documentation of medicines or treatment given before specimens were collected.
• Relevant investigative materials and prior expert assessments.

The records needed depend on the scientific question. Missing information or unavailable specimens may limit the conclusions or make additional testing impossible. An independent review does not guarantee identification of a drug or a particular outcome.